Business Context and Reporting Period
Company: Weave Communications, Inc. (WEAV)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended December 31, 2024
Business Overview: Weave provides an all-in-one customer experience and payments software platform for small and medium-sized (SMB) healthcare businesses, primarily in dental, optometry, veterinary, and medical specialty verticals. The platform integrates telephony, messaging, scheduling, payments, and AI-powered tools to streamline practice operations.
Key Financial Metrics
| Metric | 2024 | 2023 |
|---|---|---|
| Revenue | $204.3 million | $170.5 million |
| Gross Profit | $145.9 million | $116.1 million |
| Gross Margin | 71% | 68% |
| Net Loss | $(28.3) million | $(31.0) million |
| Operating Loss | $(31.4) million | $(34.4) million |
| Free Cash Flow | $10.4 million | $6.5 million |
| Adjusted EBITDA | $4.5 million | $(7.8) million |
| Cash & Equivalents | $51.6 million | $50.8 million |
| Short-term Investments | $47.5 million | $58.1 million |
| Debt Outstanding | $0 | $0 |
Liquidity: As of December 31, 2024, the company held $99.1 million in total cash, cash equivalents, and short-term investments. The company has a $50.0 million revolving line of credit with no outstanding balance and is in compliance with all covenants.
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 20% year-over-year to $204.3 million. Approximately 59% of the increase was driven by new customer locations, while 41% was driven by expansion within existing customers.
- Customer Base: Total customer locations grew to 34,997 in 2024 from 31,002 in 2023.
- Retention: Dollar-based net retention rate improved to 98% in 2024 from 95% in 2023. Gross retention rate decreased slightly to 91% from 92%.
- Profitability: The net loss narrowed by 9% to $28.3 million. Adjusted EBITDA turned positive at $4.5 million, compared to a loss of $7.8 million in 2023.
- Expense Increases: Sales and marketing expenses rose 20% to $84.6 million, and Research and Development expenses increased 18% to $40.2 million, largely due to personnel costs and stock-based compensation.
Guidance, Outlook, and Risks
Management Commentary: Management highlighted the successful launch of the enhanced Weave platform and Weave Enterprise for multi-location practices. The company expects sales and marketing expenses to decrease as a percentage of revenue in 2025. They anticipate continued investment in AI features and expansion into new healthcare verticals.
Key Risks:
- Profitability: The company has a history of losses and an accumulated deficit of $291.0 million; there is no guarantee it will achieve or sustain profitability.
- Third-Party Dependencies: Significant reliance on Google Cloud Platform (GCP) for infrastructure and Stripe for payment processing. Disruptions to these providers could materially harm operations.
- Regulatory Compliance: Subject to complex regulations including HIPAA, TCPA, and evolving data privacy laws (e.g., CPRA). Non-compliance could result in fines and reputational damage.
- Customer Concentration: While no single customer exceeds 5% of revenue, the business relies heavily on SMBs which are more susceptible to economic downturns.
- Executive Transition: The CFO, Alan Taylor, is stepping down effective March 31, 2025, with Jason Christiansen appointed as the successor effective April 1, 2025.
Investor Verification Checklist
- Verify the sustainability of the 98% net retention rate and the drivers behind the improvement from 95% in 2023.
- Assess the impact of the $32.2 million stock-based compensation expense on future cash burn and dilution.
- Review the terms and covenants of the $50 million Silicon Valley Bank credit facility, specifically the liquidity and EBITDA requirements.
- Monitor the execution of the new Weave Enterprise platform and its ability to capture multi-location healthcare organizations.
- Evaluate the risks associated with the transition of the Chief Financial Officer and the integration of the new leadership.
- Confirm the company's ability to maintain positive Adjusted EBITDA and convert it to GAAP profitability in the near term.